top of page

Biopharma Daily Stock Updates - 04/28/22

$XBI $76.19| +0.36%



Table of Contents:


Covid Updates

$MRNA +0.6% Moderna Files for Authorization of Its COVID-19 Vaccine in Young Children Six Months to Under Six Years of Age source



Pipeline Updates

$FNCH +33.8% Finch Therapeutics Announces Removal of FDA Clinical Hold on CP101 IND source


$ZYME +33.1% Zymeworks Reports Last Patient Enrolled In Pivotal Study Of Zanidatamab In Treatment Of HER2-Expressing Late-Line Biliary Tract Cancer source

$TPTX -0.5% Turning Point Therapeutics and Zai Lab Announce Topline Analysis in China Subpopulation for Repotrectinib in ROS1-Positive NSCLC Cohorts Within Global Phase 1/2 TRIDENT-1 Study source


$TMDX +6.5% TransMedics Receives FDA PMA Approval of OCS™ DCD Heart Indication source



 

Want to get weekly catalyst updates?

*We never spam you - unsubscribe anytime*

 

Business Updates

$ANVS 0.0% Annovis Bio Announces Cooperative Research and Development Agreement (CRADA) with the National Institute on Aging source

$GNCA -24.1% Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives source

 

Posted by JM

0 comments
bottom of page